Copyright
©The Author(s) 2024.
World J Clin Oncol. Apr 24, 2024; 15(4): 531-539
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.531
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.531
Figure 2 During Epithelial-mesenchymal transition, epithelial splicing regulatory protein 1 expression is reduced, promoting the transition from variant CD44 to standard CD44, and can promote liver metastasis of lung, breast, stomach, and ovarian cancers.
CD44s: Standard CD44; CD44v: Variant CD44; ESRP1: Epithelial splicing regulatory protein 1; EMT: Epithelial-mesenchymal transition.
- Citation: Geng DY, Chen QS, Chen WX, Zhou LS, Han XS, Xie QH, Guo GH, Chen XF, Chen JS, Zhong XP. Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer. World J Clin Oncol 2024; 15(4): 531-539
- URL: https://www.wjgnet.com/2218-4333/full/v15/i4/531.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i4.531